07/2024

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

07/2024

Jul 19, 2024, 15:23 | Insight
MRD testing using a ctDNA to Predict Recurrence of Metastatic Colorectal Cancer
Arndt Vogel shared on X: "MRD testing using a ctDNA to Predict Recurrence of Metastatic…
Jul 19, 2024, 14:44 | Blog
"What’s Next for Immunotherapies?" by Anas Younes
Anas Younes shared a post on LinkedIn: Immunotherapies Immunotherapies "My interview with Mark Cobbold, Senior…
Jul 19, 2024, 14:41 | Blog
DOR to Lurbinectedin in Small Cell Bladder Cancer with TP53 Mutation
Enrique Grande shared a post on X: ''Durable Objective Response to Lurbinectedin in Small Cell…
Jul 19, 2024, 14:40 | Blog
Pleasure to talk with Radan Kanev MEP, National and European Parliamentarian for Cancer Action - European Cancer Organisation
European Cancer Organisation shared on X: "Always a pleasure to talk with Radan Kanev MEP,…
Jul 19, 2024, 14:31 | Blog
Pennsylvania will become the 20th state to increase access to biomarker testing - ACS CAN Pennsylvania
ACS CAN Pennsylvania (American Cancer Society Cancer Action Network Pennsylvania) shared a post on X:…
Jul 19, 2024, 14:25 | Blog
David Fajgenbaum: Kazu Yoshizaki deserves the next Nobel Prize
David Fajgenbaum, Associate Professor of Medicine at University of Pennsylvania School of Medicine, shared on…
Jul 19, 2024, 14:19 | Blog
Registration and Housing for ASH24 is now open
ASH shared on X: “Registration and Housing for ASH24 is now OPEN for all ASH…
Jul 19, 2024, 14:12 | Blog
Kierany Shelvin: My project has been accepted as an oral presentation at CNS2024
Kierany Shelvin, Aspiring Neurosurgeon at Baylor College of Medicine, shared a post on X: ''Very…
Jul 19, 2024, 14:03 | Blog
Targeted Therapies Forum in Background Spanish by Cancer Grace Foundation
Do you have questions about targeted therapies for lung cancer? Join Cancer Grace Foundation for…
Jul 19, 2024, 14:02 | Insight
The results of the IMpassion132 trial
Elisa Agostinetto shared on X a paper by Rebecca Dent et al. titled "IMpassion132 double-blind…
All: 3004 Posts: 1151 - 1160
Special Coverage